3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
3
Other hematologic neoplasm
1
Genitourinary
1
Conditions
Prostatic Neoplasms
5
Fatigue
2
Breast Neoplasms, Male
2
Breast Neoplasms
2
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Penile Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Malnutrition
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Esophageal Neoplasms
1
Depression
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
pembrolizumab
28
Docetaxel
21
Gemcitabine
19
Nivolumab
15
Paclitaxel
13
Prednisone
12
Leuprolide
11
pazopanib
10
Radiotherapy
10
Cisplatin
10
Sunitinib
9
Sorafenib
9
Ipilimumab
8
Blood Specimen Collection
8
Bevacizumab
8
avelumab
7
atezolizumab
7
Therapeutics
7
Thalidomide
7
Cyclophosphamide
7
Carboplatin
7
Standard of Care
6
Radiation
6
Mitomycin
6
Interleukin-2
6
Cetuximab
6
Axitinib
6
padeliporfin
5
enzalutamide
5
cemiplimab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Physical Therapy Modalities
×
Genitourinary
×
Clear all
NCT05946993
2026-05-01
LIAM Mc
University College Cork
Phase NA
Active not recruiting
72 enrolled